PDAC approval extends Medicare reimbursement to Airway Management’s full line of custom oral appliances.
The Nylon flexTAP has received Pricing, Data Analysis, and Coding (PDAC) approval for HCPCS code E0486, making Airway Management’s entire portfolio of custom devices covered by Medicare under E0486.
Launched in September 2025, the Nylon flexTAP is a US Food and Drug Administration-cleared 3D-printed single-point midline oral appliance for mild to moderate obstructive sleep apnea (OSA). It combines patented Vertex Technology with digitally printed medical-grade nylon.
Key features that set Nylon flexTAP apart include:
- Patented Vertex Technology enabling dual-axis movement to maximize airway space
- 17 mm range of advancement in precise 1/3 mm increments
- Ultra-thin custom TAP trays—the thinnest custom TAP yet
- BPA-free, metal-free, biocompatible construction
- No bite registration required
- Includes Mouth Shield promoting nasal breathing (supported by peer-reviewed studies) and AM Aligner morning exerciser
- 4-year warranty
“With Nylon flexTAP now PDAC-approved for E0486, every custom TAP device we offer—from TAP 3, dreamTAP, flexTAP, and Nylon flexTAP—is fully Medicare-reimbursable,” says Charles Collins, CEO of Airway Management, in a release. “This removes reimbursement barriers for millions of Medicare beneficiaries.”
Healthcare providers can order Nylon flexTAP through Airway Labs.
